Tag Archives: anti-obesity medication

Today the FDA approved semaglutide 2.4 mg weekly injection for chronic weight management. The brand name will be Wegovy™.* The molecule semaglutide has been used for the treatment of type II diabetes for the past 5 years at doses of up to 1 mg. Novo Nordisk is also seeking an approval for a 2 mg […]

Just published in the New England Journal, as part of a weight loss program, the addition of semaglutide helped people with obesity lose an average of 15% of their body weight during 68 weeks of treatment. This equated to an average of 34 pounds of weight loss during the trial. Heart Safety of Semaglutide As […]

Saxenda is the newest medication approved by the FDA for chronic weight management. Unlike the other medications which are taken as pills or capsules, Saxenda is a once daily self-administered injection. Originally marketed as Victoza for the treatment of type 2 diabetes back in 2010, Saxenda is the same molecule (liraglutide), but underwent rigorous clinical […]

Contrave is one of our new anti-obesity medications, or “AOMs” approved for chronic weight management in 2014. As the years have gone by, we have accumulated a lot of clinical experience with Contrave for weight loss. This article will review some of the pros and cons of Contrave use, particularly in comparison to the older […]

As we celebrate Men’s health month this June, how are we doing addressing obesity among men in America? Are men receiving evidence-based weight loss treatments? Men are just as likely to suffer not only from obesity, but from the 236 other medical problems related to obesity. In fact, men with a very elevated body mass […]